TheScientist.com - Magazine of the Life Sciences, Every Day, Online
  Please Login or Register
  • Home
  • Community
  • Current Issue
  • Browse Archive
  • Careers
  • Video & Multimedia
  • Subscribe

Front Cover
Advertisement
Front Cover
Supplements
  • Life Sciences in
    the Greater
    Phila. Region
  • Schizophrenia
  • NC: State of the Life Sciences
  • Autoimmunity


Survey Series
  • Best Places to Work
  • $alary $urvey
  • Lab Web Site and
    Video Awards

The Scientist Daily
  • Science headlines delivered daily.
    Register today.

For Advertisers
  • Advertise with Us
  • Contact Ad Team
  • 2009 Media Kit



by SPIS MedWire

RESEARCH ROUND-UP

Black-blood MRI

Email: SPIS MedWire - medwire@sciencenow.com
News from The Scientist 2000, 1(1):20000814-03

Published 14 August 2000

LONDON, August 11 (SPIS MedWire) Researchers at Mount Sinai Medical School have reported the results of a pilot study involving 'black-blood' MRI — a novel means of noninvasively imaging human coronary arteries. Fayad and colleagues say that the technique, which causes the blood to appear dark while the surrounding tissue and plaques are bright, is the first to accurately image the morphological features of the vessel lumen and wall. The method was tested in 13 subjects, five of whom had coronary artery disease. In the healthy subjects, the average coronary wall thickness, as determined by black-blood MRI (BB-MRI) cross-sectional imaging, was 0.75–0.17mm. In the five CAD patients, BB-MRI identified localized wall thickening ranging from 3.3 to 5.73mm. The differences in maximum wall thickness between the two groups was statistically significant at p<0.001. The authors say the images obtained were high-quality and not affected by cardiac or respiratory motion artefacts, a significant problem with current techniques. Moreover, it requires no injection of contrast media, no incision and no insertion of a catheter. The team hope the technique 'could permit the identification of vulnerable plaques before they rupture and may provide a way to target pharmacological intervention to reduce or prevent cardiovascular disease.'


 

Email

Password

> Forgot Password?
> FAQ
> Subscribe

 
Not yet registered? Get free access
 

Subscribing to The Scientist is easy and inexpensive.

 

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.

 
  Not yet registered? Get free access  
 

The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study.
Recommend The Scientist today

 



About TS | Contact | Advertise | Editorial Advisory Board | Privacy Policy
© 1986-2008 The Scientist